enGene Therapeutics ENGN
NASDAQ ENGN
$1.56 -0.02 (-1.27%)
At close: Oct 23, 2026 · 4:00 PM EDT

enGene Therapeutics (ENGN) Common Stock Issued (2023 - 2026)

Updated

Analysis

enGene Therapeutics (ENGN) Common Stock Issued (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 743.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn -
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 6.00 Mn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 9.00 Mn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn -
10 enGene Therapeutics 104.54 Mn -889.93 Mn - 23,000.00
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 23,000.00
Apr 30, 2026 4,000.00
Jan 31, 2026 149.78 Mn
Oct 31, 2025 1.99 Mn
Jul 31, 2025 32,000.00
Apr 30, 2025 199,000.00
Jan 31, 2025 1,000.00
Oct 31, 2024 60.16 Mn
Jul 31, 2024 51,000.00
Oct 31, 2023 56.92 Mn
API Access

enGene Therapeutics Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=ENGN&period=max&api_key=YOUR_API_KEY